BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32566011)

  • 1. Expression of HIF-1α is a predictive marker of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer.
    Yan B; Ma QF; Tan WF; Cai HN; Li YL; Zhou ZG; Dai X; Zhu FX; Xiong YJ; Xu M; Guo YL; Gao H; Hu JB; Wu XF
    Oncol Lett; 2020 Jul; 20(1):841-849. PubMed ID: 32566011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreasing expression of HIF-1α, VEGF-A, and Ki67 with efficacy of neoadjuvant therapy in locally advanced cervical cancer.
    Zhao K; Hu M; Yang R; Liu J; Zeng P; Zhao T
    Medicine (Baltimore); 2023 May; 102(20):e33820. PubMed ID: 37335690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of short-term efficacy as defined by RECIST and pathological response of neoadjuvant chemotherapy comprised paclitaxel and cisplatin followed by radical surgery in patients with locally advanced cervical cancer: A prospective observational study.
    He Y; Zhao Q; Geng YN; Yang SL; Li XM; Finas D; Yin CH; Wu YM
    Medicine (Baltimore); 2018 Jun; 97(22):e10913. PubMed ID: 29851821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical efficacy and safety of paclitaxel plus carboplatin as neoadjuvant chemotherapy prior to radical hysterectomy and pelvic lymphadenectomy for Stage IB2-IIB cervical cancer.
    Yang L; Guo J; Shen Y; Cai J; Xiong Z; Dong W; Min J; Wang Z
    Int J Clin Exp Med; 2015; 8(8):13690-8. PubMed ID: 26550314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
    Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
    Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirtuin1 expression predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer.
    Teramae M; Fukuda T; Wada T; Kawanishi M; Imai K; Yamauchi M; Yasui T; Sumi T
    Mol Clin Oncol; 2015 Jan; 3(1):73-78. PubMed ID: 25469273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of hypoxia-inducible factor-1α is a predictor of poor prognosis in cervical cancer: a clinicopathologic study and a meta-analysis.
    Huang M; Chen Q; Xiao J; Yao T; Bian L; Liu C; Lin Z
    Int J Gynecol Cancer; 2014 Jul; 24(6):1054-64. PubMed ID: 24978711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
    Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
    Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
    Xiong Y; Liang LZ; Cao LP; Min Z; Liu JH
    Gynecol Oncol; 2011 Oct; 123(1):99-104. PubMed ID: 21741694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF-1α, TWIST-1 and ITGB-1, associated with Tumor Stiffness, as Novel Predictive Markers for the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Zhang J; Zhang S; Gao S; Ma Y; Tan X; Kang Y; Ren W
    Cancer Manag Res; 2020; 12():2209-2222. PubMed ID: 32273760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of epidermal growth factor-like domain 7 may be a predictive marker of the effect of neoadjuvant chemotherapy for locally advanced uterine cervical cancer.
    Yamauchi M; Fukuda T; Wada T; Kawanishi M; Imai K; Tasaka R; Yasui T; Sumi T
    Oncol Lett; 2016 Dec; 12(6):5183-5189. PubMed ID: 28105226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB.
    Minig L; Colombo N; Zanagnolo V; Landoni F; Bocciolone L; Cárdenas-Rebollo JM; Iodice S; Maggioni A
    Int J Gynecol Cancer; 2013 Nov; 23(9):1647-54. PubMed ID: 24100590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy efficacy and prognostic factors in 187 cervical cancer patients with IB2 and IIA2 stage.
    Zou T; Zheng C; Zhang Z; Yu L; Fu C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 45(3):297-304. PubMed ID: 32386022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-induced autophagy in triple negative breast cancer: association with prognostic variables, patients' survival and response to neoadjuvant chemotherapy.
    El-Guindy DM; Ibrahim FM; Ali DA; El-Horany HE; Sabry NM; Elkholy RA; Mansour W; Helal DS
    Virchows Arch; 2023 May; 482(5):823-837. PubMed ID: 36939902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of effects and postoperative clinicopathological prognosis factors of neoadjuvant chemotherapy in patients with stage Ⅰb2 and Ⅱa2 squamous cell carcinoma of the cervix].
    An JS; Zhao YX; Song Y; Li N; Huang MN; Li XG; Li B; Zhang R; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):673-679. PubMed ID: 31648443
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival.
    Buda A; Lissoni AA; Floriani I; Biagioli E; Gerardi C; Bonazzi C; Chiari S; Locatelli L; Dell'Anna T; Signorelli M; Mangioni C; Milani R
    Int J Gynecol Cancer; 2015 Oct; 25(8):1468-75. PubMed ID: 26222484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer.
    Liang Y; Lü W; Zhang X; Lü B
    Diagn Pathol; 2018 Nov; 13(1):93. PubMed ID: 30474571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and side effect analysis of paclitaxel liposome for neoadjuvant chemotherapy in locally advanced cervical cancer].
    Wang YT; Li B; Li XG; Ma SK; Zhang R; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):588-594. PubMed ID: 31550774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.